A Review of Animal Study Evidence for Mesenchymal Stem Cell Therapy to Treat Neurodegeneration
From the abstract
Researchers here assess the present animal study evidence for first generation stem cell therapies to produce benefits in the most common neurodegenerative conditions, and also the consequences of stroke. The results are promising. While these therapies have been fairly widely deployed in patients via medical tourism, that data will never be available for analysis in any useful way. A few formal clinical trials have taken place, with unfortunately mixed results, which suggests that the details o
Read the full paper
This is a preview. The primary source is hosted externally — past100 links directly to the original journal paper, not a news article about it.
View original paper →Get our analysis
Each week past100 selects one paper and breaks it down: study design, effect sizes, caveats, and what a rational evidence-informed person should do with the information.
Subscribe free →